이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Alkem Laboratories 미래 성장
Future 기준 확인 2/6
Alkem Laboratories (는) 각각 연간 13.6% 및 9.6% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 13.2% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 17.3% 로 예상됩니다.
주요 정보
13.6%
수익 성장률
13.1%
EPS 성장률
Pharmaceuticals 수익 성장 | 17.1% |
매출 성장률 | 9.6% |
향후 자기자본 수익률 | 17.2% |
애널리스트 커버리지 | Good |
마지막 업데이트 | 26 Jun 2024 |
최근 미래 성장 업데이트
Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
Jun 01Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets
Feb 13Recent updates
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year
Jun 27Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00
Jun 13Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
Jun 01Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)
May 22Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets
Feb 13Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects
Jan 17We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease
Dec 27Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Sep 14Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Aug 02Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Jul 07Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
May 22We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt
Mar 27Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Dec 26These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well
Sep 20Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00
Jul 27Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 13Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Jun 11Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
May 23Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Mar 06Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Feb 21Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Feb 08Should You Be Adding Alkem Laboratories (NSE:ALKEM) To Your Watchlist Today?
Jan 09Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Nov 30Here's Why Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt Responsibly
Nov 17I Built A List Of Growing Companies And Alkem Laboratories (NSE:ALKEM) Made The Cut
Sep 07Here's Why Alkem Laboratories Limited's (NSE:ALKEM) CEO May Deserve A Raise
Aug 20Alkem Laboratories (NSE:ALKEM) Is Increasing Its Dividend To ₹5.00
Aug 03Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Jul 19Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Jul 01수익 및 매출 성장 예측
날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
---|---|---|---|---|---|
3/31/2027 | 169,447 | 26,442 | 18,721 | 23,969 | 10 |
3/31/2026 | 154,532 | 24,867 | 16,473 | 21,712 | 21 |
3/31/2025 | 139,911 | 21,453 | 11,729 | 22,294 | 21 |
3/31/2024 | 126,676 | 17,958 | 16,888 | 19,481 | N/A |
12/31/2023 | 126,344 | 15,732 | N/A | N/A | N/A |
9/30/2023 | 123,514 | 14,329 | 18,370 | 20,537 | N/A |
6/30/2023 | 119,906 | 11,433 | N/A | N/A | N/A |
3/31/2023 | 115,993 | 9,842 | 14,496 | 16,825 | N/A |
12/31/2022 | 111,805 | 10,208 | N/A | N/A | N/A |
9/30/2022 | 107,586 | 10,917 | 5,527 | 8,426 | N/A |
6/30/2022 | 104,792 | 13,051 | N/A | N/A | N/A |
3/31/2022 | 106,342 | 16,456 | 7,721 | 11,110 | N/A |
12/31/2021 | 103,425 | 17,780 | N/A | N/A | N/A |
9/30/2021 | 100,416 | 17,033 | 10,478 | 13,213 | N/A |
6/30/2021 | 96,044 | 16,311 | N/A | N/A | N/A |
3/31/2021 | 88,650 | 15,850 | 11,051 | 12,649 | N/A |
12/31/2020 | 87,218 | 15,338 | N/A | N/A | N/A |
9/30/2020 | 85,971 | 14,648 | 8,916 | 11,455 | N/A |
6/30/2020 | 84,984 | 13,636 | N/A | N/A | N/A |
3/31/2020 | 83,444 | 11,271 | 2,220 | 5,851 | N/A |
12/31/2019 | 81,484 | 11,057 | N/A | N/A | N/A |
9/30/2019 | 78,929 | 9,262 | 5,173 | 8,756 | N/A |
6/30/2019 | 75,478 | 8,098 | N/A | N/A | N/A |
3/31/2019 | 73,572 | 7,605 | 2,505 | 7,797 | N/A |
12/31/2018 | 70,157 | 6,602 | N/A | N/A | N/A |
9/30/2018 | 68,318 | 6,293 | N/A | N/A | N/A |
6/30/2018 | 67,788 | 6,955 | N/A | N/A | N/A |
3/31/2018 | 63,918 | 6,309 | -4,177 | 2,660 | N/A |
12/31/2017 | 60,044 | 7,009 | N/A | N/A | N/A |
9/30/2017 | 57,285 | 7,626 | N/A | N/A | N/A |
6/30/2017 | 55,019 | 7,248 | N/A | N/A | N/A |
3/31/2017 | 56,875 | 8,920 | N/A | 4,711 | N/A |
12/31/2016 | 56,933 | 7,732 | N/A | N/A | N/A |
9/30/2016 | 54,992 | 7,267 | N/A | N/A | N/A |
6/30/2016 | 52,419 | 7,108 | N/A | N/A | N/A |
3/31/2016 | 49,248 | 7,416 | N/A | 7,258 | N/A |
12/31/2015 | 47,975 | 8,189 | N/A | N/A | N/A |
9/30/2015 | 44,556 | 7,227 | N/A | 4,023 | N/A |
6/30/2015 | 40,459 | 5,781 | N/A | N/A | N/A |
3/31/2015 | 37,434 | 3,916 | N/A | 3,255 | N/A |
3/31/2014 | 31,191 | 4,353 | N/A | 2,900 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: ALKEM 의 연간 예상 수익 증가율( 13.6% )이 saving rate( 6.7% 보다 높습니다. ).
수익 vs 시장: ALKEM 의 연간 수익( 13.6% ) Indian 시장( 15.9% 보다 느리게 성장할 것으로 예상됩니다. 15.9% 연간).
고성장 수익: ALKEM 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.
수익 대 시장: ALKEM 의 수익(연간 9.6% ) Indian 시장( 9.5% 보다 빠르게 성장할 것으로 예상됩니다. 9.5% 연간).
고성장 수익: ALKEM 의 수익(연간 9.6% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: ALKEM 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 17.3 %).